Jay M. Short Ph.D., Chief Executive Officer at BioAtla, Inc. (BCAB), bought 81,600 shares at $2.47 ($202K) on 2023-03-29, disclosed to the SEC on 2023-03-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.47 | 40,800 | $101K | 50.0% |
| 2 | $2.47 | 40,800 | $101K | 50.0% |
| Total | $2.47 avg | 81,600 | $202K | 100% |
| Filing → |
| BCAB | BUY | 2022-06-23 | $397K | — | Filing → |
| BCAB | SELL | 2021-12-07 | $2.1M | — | Filing → |
| BCAB | SELL | 2021-12-06 | $737K | — | Filing → |